Alon Ben Nun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Alon Ben Nun has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
David Simansky
Department of General Thoracic Surgery, Sheba Medical Center, and Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
4 shared publicationsMichalle Soudack
Department of Imaging, Sheba Medical Center, and Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
4 shared publications- Amir Onn
The Sheba Lung Transplant Program, Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
3 shared publications - David Simansky
Department of Thoracic Surgery, Chaim Sheba Medical Center, Tel Hashomer, Affiliated to Sackler Faculty of Medicine, Tel Aviv University , Ramat Gan , Israel
3 shared publications - Jair Bar
Jusidman Cancer Center, Sheba Medical Center, Ramat Gan, Israel
3 shared publications Nir Golan
Department of General Thoracic Surgery, Sheba Medical Center, and Sackler School of Medicine, Tel-Aviv University, Tel Aviv, Israel
3 shared publications
Latest Publications
- 1 April 2019
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 92 (1097) , 20180960
Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes
Objective: Intensity-modulated radiotherapy (IMRT) has better normal-tissue sparing compared with 3-dimensional conformal radiation (3DCRT). We sought to assess the impact of radiation technique on pathological and clinical outcomes in locally advanced non-small cell lung cancer (LANSCLC) treated with a trimodality strategy. Methods: Retrospective review of LANSCLC patients treated from August 2012 to August 2018 at Sheba Medical Center, Israel. The trimodality strategy consisted of concomitant chemoradiation to 60 Gray (Gy) followed by completion surgery. The planning target volume (PTV) was defined by co-registered PET/CT. Here we compare the pathological regression, surgical margin status, local control rates (LC), disease free (DFS) and overall survival (OS) between 3DCRT and IMRT. Results: Our cohort consisted of 74 patients with mean age 62.9 years, male in 51/74 (69%), adenocarcinoma in 46/74 (62.1%), stage 3 in 59/74 (79.7%) and chemotherapy in 72/74 (97.3%). Radiation mean dose: 59.2 Gy (SD ± 3.8). Radiation technique : 3DCRT in 51/74 (68.9%), IMRT in 23/74 (31%). Other variables were similar between groups.Major pathological response (including pathological complete response or less than 10% residual tumor cells) was similar: 32/51 (62.7%) in 3DCRT and 15/23 (65.2%) in IMRT, p=0.83. Pathological complete response (pCR) rates were similar: 17/51 (33.3%) in 3DCRT and 8/23 (34.8%) in IMRT, p=0.9. Surgical margins were negative in 46/51 (90.1%) in 3DCRT vs. 17/19 (89.4%) in IMRT (p=1.0).The 2-year LC rates were 81.6% (95% CI 69-89.4%); DFS 58.3% (95% CI 45.5-69%) and 3-year OS 70% (95% CI57-80%). Comparing radiation techniques, there were no significant differences in LC (p=0.94), DFS (p=0.33) and OS (p=0.72). Conclusion: When used to treat LANSCLC in the neoadjuvant setting, both IMRT and 3DCRT produce comparable pathological and clinical outcomes. Advances in knowledge: This study validates the real-world effectiveness of IMRT compared to 3DCRT.
- 1 April 2019
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 92 (1097) , 20180960
Comparative effectiveness of intensity modulated radiation therapy to 3-dimensional conformal radiation in locally advanced lung cancer: pathological and clinical outcomes
Objective: Intensity-modulated radiotherapy (IMRT) has better normal-tissue sparing compared with 3-dimensional conformal radiation (3DCRT). We sought to assess the impact of radiation technique on pathological and clinical outcomes in locally advanced non-small cell lung cancer (LANSCLC) treated with a trimodality strategy. Methods: Retrospective review of LANSCLC patients treated from August 2012 to August 2018 at Sheba Medical Center, Israel. The trimodality strategy consisted of concomitant chemoradiation to 60 Gray (Gy) followed by completion surgery. The planning target volume (PTV) was defined by co-registered PET/CT. Here we compare the pathological regression, surgical margin status, local control rates (LC), disease free (DFS) and overall survival (OS) between 3DCRT and IMRT. Results: Our cohort consisted of 74 patients with mean age 62.9 years, male in 51/74 (69%), adenocarcinoma in 46/74 (62.1%), stage 3 in 59/74 (79.7%) and chemotherapy in 72/74 (97.3%). Radiation mean dose: 59.2 Gy (SD ± 3.8). Radiation technique : 3DCRT in 51/74 (68.9%), IMRT in 23/74 (31%). Other variables were similar between groups.Major pathological response (including pathological complete response or less than 10% residual tumor cells) was similar: 32/51 (62.7%) in 3DCRT and 15/23 (65.2%) in IMRT, p=0.83. Pathological complete response (pCR) rates were similar: 17/51 (33.3%) in 3DCRT and 8/23 (34.8%) in IMRT, p=0.9. Surgical margins were negative in 46/51 (90.1%) in 3DCRT vs. 17/19 (89.4%) in IMRT (p=1.0).The 2-year LC rates were 81.6% (95% CI 69-89.4%); DFS 58.3% (95% CI 45.5-69%) and 3-year OS 70% (95% CI57-80%). Comparing radiation techniques, there were no significant differences in LC (p=0.94), DFS (p=0.33) and OS (p=0.72). Conclusion: When used to treat LANSCLC in the neoadjuvant setting, both IMRT and 3DCRT produce comparable pathological and clinical outcomes. Advances in knowledge: This study validates the real-world effectiveness of IMRT compared to 3DCRT.
- 15 November 2017
- Published by Wiley in World Journal of Surgery
- Vol. 42 (6) , 1792-1797
Surgical Treatment of Gastro‐Pulmonary Fistula Following Bariatric Surgery: Possible and Safe
Laparoscopic sleeve gastrectomy is a common surgical management of morbid obesity. Major complication rate is 3–8%. Staple line leak is one of the most serious complications. In a small group of patients, a gastro-pulmonary fistula is formed. Endoscopic and minimally invasive measures are the first line of treatment with considerable success rate. There are very poor data in the literature what should be done in cases of failure. In this paper, we report our positive experience with definitive surgical repair.
- 15 November 2017
- Published by Wiley in World Journal of Surgery
- Vol. 42 (6) , 1792-1797
Surgical Treatment of Gastro‐Pulmonary Fistula Following Bariatric Surgery: Possible and Safe
Laparoscopic sleeve gastrectomy is a common surgical management of morbid obesity. Major complication rate is 3–8%. Staple line leak is one of the most serious complications. In a small group of patients, a gastro-pulmonary fistula is formed. Endoscopic and minimally invasive measures are the first line of treatment with considerable success rate. There are very poor data in the literature what should be done in cases of failure. In this paper, we report our positive experience with definitive surgical repair.
- 22 July 2015
- Published by Springer Nature in Surgery Today
- Vol. 46 (6) , 686-690
Hybrid video-assisted and limited open (VALO) resection of superior sulcus tumors
To compare the postoperative recovery of patients with superior sulcus tumors (Pancoast tumors) following conventional open surgery vs. a hybrid video-assisted and limited open approach (VALO). The subjects of this retrospective study were 20 patients we operated on to resect a Pancoast tumor. All patients received induction chemo-radiation followed by surgery, performed via either a conventional thoracotomy approach (n = 10) or the hybrid VALO approach (n = 10). In the hybrid VALO group, lobectomy and internal chest wall preparation were performed using a video technique, with rib resection and specimen removal through a limited incision. There was no mortality in either group. Two patients from the thoracotomy group required mechanical ventilation, but there was no major morbidity in the hybrid VALO group. The operative times were similar for the two procedures. The average length of hospital stay was shorter and the average pain scores were significantly lower in the hybrid VALO group. The incidence of chronic pain was 10 % in the hybrid VALO group vs. 50 % in the thoracotomy group. Hybrid VALO resection of Pancoast tumors is feasible and safe, resulting in faster patient recovery and a significantly lower incidence of severe chronic pain than open thoracotomy. We conclude that centers experienced with video-assisted lobectomy should consider hybrid VALO surgery as the procedure of choice for Pancoast tumors.
- 22 July 2015
- Published by Springer Nature in Surgery Today
- Vol. 46 (6) , 686-690
Hybrid video-assisted and limited open (VALO) resection of superior sulcus tumors
To compare the postoperative recovery of patients with superior sulcus tumors (Pancoast tumors) following conventional open surgery vs. a hybrid video-assisted and limited open approach (VALO). The subjects of this retrospective study were 20 patients we operated on to resect a Pancoast tumor. All patients received induction chemo-radiation followed by surgery, performed via either a conventional thoracotomy approach (n = 10) or the hybrid VALO approach (n = 10). In the hybrid VALO group, lobectomy and internal chest wall preparation were performed using a video technique, with rib resection and specimen removal through a limited incision. There was no mortality in either group. Two patients from the thoracotomy group required mechanical ventilation, but there was no major morbidity in the hybrid VALO group. The operative times were similar for the two procedures. The average length of hospital stay was shorter and the average pain scores were significantly lower in the hybrid VALO group. The incidence of chronic pain was 10 % in the hybrid VALO group vs. 50 % in the thoracotomy group. Hybrid VALO resection of Pancoast tumors is feasible and safe, resulting in faster patient recovery and a significantly lower incidence of severe chronic pain than open thoracotomy. We conclude that centers experienced with video-assisted lobectomy should consider hybrid VALO surgery as the procedure of choice for Pancoast tumors.
- 20 May 2014
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (15_suppl) , 7560
Breath analysis as a noninvasive biomarker for early detection of lung cancer.
7560 Background: The search for non-invasive diagnostic methods of lung cancer (LC) has led to new avenues of research, including the exploration of the exhaled breath. Previous studies have shown that LC can be detected through exhaled-breath analysis. This study evaluated the potential of exhaled-breath analysis for the distinction of early and advanced LC and for control (COPD) and lung cancer patients in an international setting. Methods: Breath samples were taken from untreated lung cancer patients and matching COPD controls. Patients were enrolled in Israel, Colorado and Florida. All samples were analyzed in a central lab (Technion Institute; Haifa, Israel). Analysis was performed by both gold nanoparticle-based Artificial Olfactory System (NaNose) and gas-chromatography linked with mass-spectrometry (GC-MS). Pattern recognition methods were used to analyze the results obtained from GC-MS and NaNose to correlate the results with the clinical data. Results: A total of 358 subjects were enrolled in this study (Israel: 174; Denver: 111; Florida: 73). 213 patients had lung cancer, among 62 early disease and 143 were at advanced stage. 145 patients did not have cancer. In our preliminary sub-analysis, of 80 cancer patients (64 advanced stage) and 31 COPDs subjects: discriminant function analysis of the signals of the sensor array distinguished significantly between control versus early LC (p < 0.0001; accuracy 85.11%), between control and advanced LC (p < 0.0001; 82.11%) and between early and advanced LC (p< 0.0001; 78.75%). Conclusions: In this multi-national pilot study, breath analysis discriminated malignant disease from benign conditions in a high-risk cohort based on LC-related volatile organic compound profiles. Furthermore, it discriminated between early versus advanced disease. These achievements stand in consistency with the requirements of society for rapid and early diagnosis of diseases as a part of therapeutic approach and facilitating rapid treatment. Clinical trial information: NCT01386203.
- 20 May 2014
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 32 (15_suppl) , 7560
Breath analysis as a noninvasive biomarker for early detection of lung cancer.
7560 Background: The search for non-invasive diagnostic methods of lung cancer (LC) has led to new avenues of research, including the exploration of the exhaled breath. Previous studies have shown that LC can be detected through exhaled-breath analysis. This study evaluated the potential of exhaled-breath analysis for the distinction of early and advanced LC and for control (COPD) and lung cancer patients in an international setting. Methods: Breath samples were taken from untreated lung cancer patients and matching COPD controls. Patients were enrolled in Israel, Colorado and Florida. All samples were analyzed in a central lab (Technion Institute; Haifa, Israel). Analysis was performed by both gold nanoparticle-based Artificial Olfactory System (NaNose) and gas-chromatography linked with mass-spectrometry (GC-MS). Pattern recognition methods were used to analyze the results obtained from GC-MS and NaNose to correlate the results with the clinical data. Results: A total of 358 subjects were enrolled in this study (Israel: 174; Denver: 111; Florida: 73). 213 patients had lung cancer, among 62 early disease and 143 were at advanced stage. 145 patients did not have cancer. In our preliminary sub-analysis, of 80 cancer patients (64 advanced stage) and 31 COPDs subjects: discriminant function analysis of the signals of the sensor array distinguished significantly between control versus early LC (p < 0.0001; accuracy 85.11%), between control and advanced LC (p < 0.0001; 82.11%) and between early and advanced LC (p< 0.0001; 78.75%). Conclusions: In this multi-national pilot study, breath analysis discriminated malignant disease from benign conditions in a high-risk cohort based on LC-related volatile organic compound profiles. Furthermore, it discriminated between early versus advanced disease. These achievements stand in consistency with the requirements of society for rapid and early diagnosis of diseases as a part of therapeutic approach and facilitating rapid treatment. Clinical trial information: NCT01386203.
- 1 March 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 97 (3) , 1091-1092
Electric Suction-Lavage Device for Video-Assisted Thoracoscopic Surgery Treatment of Empyema and Hemothorax
- 1 March 2014
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 97 (3) , 1091-1092
Electric Suction-Lavage Device for Video-Assisted Thoracoscopic Surgery Treatment of Empyema and Hemothorax
- 28 February 2014
- Published by Springer Nature in memo - Magazine of European Medical Oncology
- Vol. 7 (1) , 10-15
Evaluation of EGFR, KRAS, and TP53 mutations as predictive of disease recurrence in resected early non-small cell lung carcinomas (NSCLCs)
- 28 February 2014
- Published by Springer Nature in memo - Magazine of European Medical Oncology
- Vol. 7 (1) , 10-15
Evaluation of EGFR, KRAS, and TP53 mutations as predictive of disease recurrence in resected early non-small cell lung carcinomas (NSCLCs)
- Open Access
- 8 January 2013
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 44 (1) , 79-82
Fluorodeoxyglucose—positive internal mammary lymph node in breast cancer patients with silicone implants: is it always metastatic cancer?
Patients with breast cancer following mastectomy and silicone implant reconstruction may have enlarged internal mammary lymph nodes with pathological uptake on positron emission tomography with 18F-fluorodeoxyglucose. This lymphadenopathy is usually considered as metastatic in nature, but has also been reported to be related to other conditions, including silicon migration. The purpose of this study was to determine the rate of metastatic disease in this unique group of patients. A retrospective comparative study of 12 female patients with breast cancer with silicone implants referred for biopsy due to isolated internal mammary lymph node fluorodeoxyglucose uptake on positron emission tomography. Five patients (41.6%) had histological findings related to silicone (n = 4) or non-specific inflammation (n = 1). The remaining 7 (58.3%) had histological evidence of cancer recurrence. There was no significant difference in the fluorodeoxyglucose-standardized uptake value between the two groups. Fluorodeoxyglucose-positive mammary lymph nodes in patients with breast cancer following silicone implant reconstruction may be due to metastatic deposits, non-specific inflammation or silicone migration. Clinical and imaging characteristics are insufficient in differentiating between these conditions. Biopsy is recommended prior to initiation of further treatment.
- 8 January 2013
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 44 (1) , 79-82
Open AccessFluorodeoxyglucose—positive internal mammary lymph node in breast cancer patients with silicone implants: is it always metastatic cancer?
Patients with breast cancer following mastectomy and silicone implant reconstruction may have enlarged internal mammary lymph nodes with pathological uptake on positron emission tomography with 18F-fluorodeoxyglucose. This lymphadenopathy is usually considered as metastatic in nature, but has also been reported to be related to other conditions, including silicon migration. The purpose of this study was to determine the rate of metastatic disease in this unique group of patients. A retrospective comparative study of 12 female patients with breast cancer with silicone implants referred for biopsy due to isolated internal mammary lymph node fluorodeoxyglucose uptake on positron emission tomography. Five patients (41.6%) had histological findings related to silicone (n = 4) or non-specific inflammation (n = 1). The remaining 7 (58.3%) had histological evidence of cancer recurrence. There was no significant difference in the fluorodeoxyglucose-standardized uptake value between the two groups. Fluorodeoxyglucose-positive mammary lymph nodes in patients with breast cancer following silicone implant reconstruction may be due to metastatic deposits, non-specific inflammation or silicone migration. Clinical and imaging characteristics are insufficient in differentiating between these conditions. Biopsy is recommended prior to initiation of further treatment.
- 1 January 2013
- Published by Termedia Sp. z.o.o. in Polish Journal of Cardio-Thoracic Surgery
- Vol. 4, 347-351
Cardiac surgery Long-term results after concomitant cardiac surgery and pulmonary resection
Background: Concomitant lesions of the heart and lung are uncommon, but when present they pose a challenge for cardiac and thoracic surgeons. Patients with lung cancer and heart disease are at a high risk for postoperative death or severe cardiovascular complications. Aim of the study:...
- 1 January 2013
- Published by Termedia Sp. z.o.o. in Polish Journal of Cardio-Thoracic Surgery
- Vol. 4, 347-351
Cardiac surgery Long-term results after concomitant cardiac surgery and pulmonary resection
Background: Concomitant lesions of the heart and lung are uncommon, but when present they pose a challenge for cardiac and thoracic surgeons. Patients with lung cancer and heart disease are at a high risk for postoperative death or severe cardiovascular complications. Aim of the study:...
- 1 September 2011
- Published by Wiley in World Journal of Surgery
- Vol. 35 (11) , 2563-2567
Nonsteroidal Antiinflammatory Medications: Efficient and Safe Treatment Following Video‐Assisted Pleurodesis for Spontaneous Pneumothorax
Background Recurrent spontaneous pneumothorax is widely treated by video-assisted thoracoscopic (VATS) bullectomy and pleurodesis. Treatment of postoperative pain with nonsteroidal antiinflammatory drugs (NSAIDs) is controversial as many surgeons believe that it reduces the efficacy of pleurodesis and increases the pneumothorax recurrence rate. Methods In this retrospective study, we reviewed the hospital records for patients following VATS pleurodesis for recurrent spontaneous pneumothorax. The patients were divided into two groups: (1) NSAID group: patients were treated with NSAIDs for more than a week following surgery and (2) control group: patients did not receive NSAIDs. Data regarding short- and long-term outcomes were compared. Results The study cohort included 105 patients: 48 in the NSAID group and 57 in the control group. During the early postoperative period the average daily requirement of narcotic analgesia and the incidence of narcotic-related side effects were lower in the NSAIDs group. No difference was found in the long-term recurrence rate: two of 48 (4%) in the NSAID group and three of 57 (5%) in the control group. There was one case of early recurrence in the NSAID group. Both groups had similar length of stay with no cases of mortality or major morbidity. Conclusions NSAIDs for postsurgical pleurodesis pain obviates the need for narcotics without increasing the pneumothorax recurrence rate. Prospective randomized controlled studies are needed to further investigate this issue.
- 1 September 2011
- Published by Wiley in World Journal of Surgery
- Vol. 35 (11) , 2563-2567
Nonsteroidal Antiinflammatory Medications: Efficient and Safe Treatment Following Video‐Assisted Pleurodesis for Spontaneous Pneumothorax
Background Recurrent spontaneous pneumothorax is widely treated by video-assisted thoracoscopic (VATS) bullectomy and pleurodesis. Treatment of postoperative pain with nonsteroidal antiinflammatory drugs (NSAIDs) is controversial as many surgeons believe that it reduces the efficacy of pleurodesis and increases the pneumothorax recurrence rate. Methods In this retrospective study, we reviewed the hospital records for patients following VATS pleurodesis for recurrent spontaneous pneumothorax. The patients were divided into two groups: (1) NSAID group: patients were treated with NSAIDs for more than a week following surgery and (2) control group: patients did not receive NSAIDs. Data regarding short- and long-term outcomes were compared. Results The study cohort included 105 patients: 48 in the NSAID group and 57 in the control group. During the early postoperative period the average daily requirement of narcotic analgesia and the incidence of narcotic-related side effects were lower in the NSAIDs group. No difference was found in the long-term recurrence rate: two of 48 (4%) in the NSAID group and three of 57 (5%) in the control group. There was one case of early recurrence in the NSAID group. Both groups had similar length of stay with no cases of mortality or major morbidity. Conclusions NSAIDs for postsurgical pleurodesis pain obviates the need for narcotics without increasing the pneumothorax recurrence rate. Prospective randomized controlled studies are needed to further investigate this issue.
- 1 January 2006
- Published by Elsevier in Respiratory Medicine Extra
- Vol. 2 (3) , 92-94
Delayed diagnosis of pleural complications in ventriculoperitoneal shunt—Case reports of three patients
- 1 January 2006
- Published by Elsevier in Respiratory Medicine Extra
- Vol. 2 (3) , 92-94
Delayed diagnosis of pleural complications in ventriculoperitoneal shunt—Case reports of three patients